Judkins Brian C's Form 4 filing
Chemed Corp (CHE) · filed Mar 22, 2024
- Accession no.
- 0000950170-24-035162
- Filed
- Mar 22, 2024
- Trade date
- Mar 20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.20M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000950170-24-138847 (Dec 20, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Judkins Brian CCIK 0001823398 | Officer (VP and Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | Capital Stock | MOption exerciseAcquired | +5,825 | $413.19 | +$2,406,831.75 | 6,447 | Direct | |
| Mar 20, 2024 | Capital Stock | MOption exerciseAcquired | +6,133 | $471.74 | +$2,893,181.42 | 12,580 | Direct | |
| Mar 20, 2024 | Capital Stock | SSaleDisposed | −11,158 | $645.00F1 | −$7,196,910 | 1,422 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | Capital Stock | MOption exerciseDisposed | −5,825 | $413.19 | −$2,406,831.75 | 29,183 | Direct | |
| Mar 20, 2024 | Capital Stock | MOption exerciseDisposed | −6,133 | $471.74 | −$2,893,181.42 | 23,050 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiples transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Referenced by the price of 1 transaction in Table I.